Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adrian Smith

Plastic Surgery Within the Head and Neck Flowood, MS Medical Doctor

NPI 1578508735 CMS profile 252278

2550 Flowood Dr, Suite 200, Flowood, MS 39232

Open in the dashboard

General payments

$1,604

43 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adrian Smith of Flowood, MS is reported in the CMS Open Payments database as having received $1,604 across 43 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 46th percentile of Plastic Surgery Within the Head and Neck profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $20 1
2024 General $71 3
2023 General $206 4
2022 General $588 15
2021 General $448 12
2020 General $51 3
2019 General $220 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adrian Smith
  • Plastic Surgery Within the Head and Neck median
  • Middle half of Plastic Surgery Within the Head and Neck
  • National median

In program year 2025, general payments to Adrian Smith were reported at $20. Among 103 Plastic Surgery Within the Head and Neck profiles paid that year, the median was $300 and the middle half received between $115 and $580.

Show as a table
Year Adrian Smith Plastic Surgery Within the Head and Neck median Middle half National median
2019 $220 $270 $76–$780 $163
2020 $51 $172 $52–$421 $114
2021 $448 $227 $64–$753 $132
2022 $588 $338 $112–$800 $149
2023 $206 $303 $89–$723 $160
2024 $71 $289 $115–$714 $164
2025 $20 $300 $115–$580 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Mentor Worldwide LLC $889 25 payments
  2. Allergan Inc. $257 11 payments
  3. Acist Medical Systems, Inc. $149 1 payment
  4. DePuy Synthes Sales Inc. $133 1 payment
  5. AxoGen $112 1 payment
  6. AbbVie, Inc. $33 2 payments
  7. Tactile Systems Technology Inc $17 1 payment
  8. Galderma Laboratories, L.P. $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,604 43 payments
Products named General payments · program years 2019–2025
  1. MENTOR MemoryGel Resterilizable Gel Sizer $812 23 payments
  2. ARTOURA Breast Tissue Expander Plastic Surgery $781 22 payments
  3. BOTOX $182 6 payments
  4. HD-IVUS $149 1 payment
  5. NA $133 1 payment
  6. AxoGuard Nerve Connector $112 1 payment
  7. AXOGUARD NERVE PROTECTOR $112 1 payment
  8. MemoryGel Breast Implants $78 2 payments
  9. ARTOURA Breast Tissue Expander Plastic Surgery $78 2 payments
  10. FlexHD Acellular Hydrated Dermis $40 1 payment
  11. Other $159 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

87

Median for Plastic and Reconstructive Surgery: 61

Drug cost

$1,511

Median for Plastic and Reconstructive Surgery: $369

Branded share of claims

43.7%

Median for Plastic and Reconstructive Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Fluorouracil Generic 17 $1,152
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 24 $185
Mupirocin Generic 19 $90
Promethazine Hcl Generic 13 $58
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 14 $25

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 81 billing codes

Paid by Medicare

$48,131

Medicare's payments for the services billed

Medicare patients

139

Average age 74

Services billed

408

67 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 47%
Diabetes 36%
Ischemic heart disease 35%
Atrial fibrillation 20%
COPD 19%
Cancer 19%
Depression 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

43 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery Within the Head and Neck in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record